Veradigm (NASDAQ:MDRX) Shares Gap Up – Should You Buy?

Veradigm Inc. (NASDAQ:MDRX – Get Free Report) gapped up prior to trading on Wednesday. The stock had previously closed at $4.75, but opened at $5.00. Veradigm shares last traded at $5.00, with a volume of 782 shares changing hands.

Veradigm Trading Up 3.2%

The company has a market cap of $599.27 million, a price-to-earnings ratio of 23.25 and a beta of 0.51. The stock has a 50 day moving average price of $4.89 and a two-hundred day moving average price of $4.82.

About Veradigm

(Get Free Report)

Veradigm Inc (NASDAQ:MDRX), formerly known as Allscripts Healthcare Solutions, is a healthcare technology company that provides software, data and connectivity solutions for healthcare organizations, physicians, patients, payers and life sciences companies. The company changed its name to Veradigm in 2023 to reflect its broader focus on using healthcare data to support clinical, operational and commercial decision-making.

Veradigm’s offerings include electronic health record and practice-management solutions, electronic prescribing, revenue-cycle and financial management tools, patient engagement services and healthcare information-exchange capabilities.

Further Reading

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.